Aurobindo Pharma
Update in progressAUROPHARMA.NS (NSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Aurobindo Pharma Limited is a biopharmaceutical company that develops, manufactures, and sells generic medicines, APIs, and injectables. It offers oral solids and liquids, injectables, vaccines, and metered dose inhalers, plus APIs, biosimilars, and peptides. Therapeutic areas include CNS, cardiovascular, respiratory, antibiotics, HIV, diabetes, GI, oncology, and dermatology. It operates in India, the US, Europe, Puerto Rico, and other international markets. Headquartered in Hyderabad.
Company score
- Sentiment
- 1.09
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- -0.46
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 1.28
- Governance
- -0.49
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.12
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.61
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!